SBC Medical Group Holdings Incorporated notified Nasdaq that it is no longer in compliance with independence rules following Mike Sayama's decision not to seek re-election. Nasdaq has granted the Company a cure period until July 9, 2027, to regain compliance by increasing its Board and Audit Committee membership. Stockholders also approved several charter amendments, including removing the requirement for directors to be elected by plurality and allowing for the removal of directors without cause. SBC Medical Group Holdings Incorporated operates in the medical services industry and provides aesthetic and medical services.